U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07123701) titled 'Clinical Study of Tanshinone Capsules Against COVID-19' on Aug. 11.
Brief Summary: The variation of SARS-CoV-2 has caused many countries to face the problem of multiple outbreaks. Gene mutations can change the transmicity, pathogenicity, and immunogenicity of the virus. For example, the Omicron variant circulating around the world spreads faster, increases infectivity, and infects a younger population, which in turn affects the efficacy of antiviral drugs or weakens the protective efficiency of vaccines. Therefore, in order to fully respond to the variation of SARS-CoV-2 and possible new coronaviruses in the future, the development ...